Table 1.

Patient characteristics

Case no.Sex/Age, yYear of initial diagnosisStageTherapy of initial diseaseTherapy of first relapseFollow-up (y)Outcome
1F/202006II AABVDDHAP, RT, BEAM + AUTO-SCT, ALLO-SCT3Alive
2F/751992II BABVD + RTNone1Dead
3M/272001II BBEACOPP + RTDHAP, RT, IMVP16 + AUTO - SCT2Dead
4F/862006III AABVDNot available2Dead
5M/672006II AABVDBEACOPPesc3Alive
6M/182004III ASBEACOPPDHAP, BEAM + AUTO-SCT4Alive
7M/52006III AOEPA + COPP + RTNot available3Alive
8M/212003III BBEACOPPescNot available4Alive
9M/531997IV BCOPP–ABVD + RTDHAP, EPOCH + AUTO-SCT7Alive
10F/372002II AABVD + RTBEACOPPesc8Alive
11M/201999II AABVD + RTDHAP, RT, BEAM + AUTO-SCT10Alive
12F/482001IV BBEACOPPesc + RTDHAP, BEAM + AUTO - SCT7Alive
13F/391993II AABVDDHAP, EPOCH + AUTO-SCT9Alive
14M/642002III BNot availableNot available7Alive
15M/232001III BABVDBEACOPPesc7Dead
16M/361999II AABVDBEACOPPesc10Alive
17F/201997IV BMOPP-ABVD + BEAM + AUTO-SCT-RTBEACOPPesc, DHAP + 2xALLO-SCT13Alive
18M/201994IV BCOPP-ABVD + RTBEACOPPesc, DHAP + AUTO-SCT15Alive
19M/331997II ABEACOPP + RTDHAP + AUTO-SCT12Alive
20F/221991III BBEACOPP + RTBEACOPP, DHAP + AUTO-SCT15Clinical recurrence
21M/452001III BABVDR-CEOP8Dead
22F/692000I ACHOP + RTABVD9Alive

Abbreviations: ABVD, adriamycin, bleomycin, vinblastine, dacarbazine; ALLO-SCT, allogeneic stem cell transplantation; AUTO-SCT, autologous stem cell transplantation; BEACOPP, bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone; BEACOPPesc, BEACOPP escalated; BEAM, carmustine, etoposide, cytarabine, melphalan; CHOP, cyclophosphamide, adriamycin, vincristine, prednisone; COPP, cyclophosphamide, vincristine, procarbazine, prednisone; DHAP, cytarabine, cisplatin, dexamethasone; F, female; ICE, ifosfamide, carboplatin, etoposide; IMVP16, ifosfamide, methotrexate, etoposide; M, male; MOPP, mechlorethamine, vincristine, procarbazine, prednisone; OEPA, vincristine, etoposide, prednisone, adriamycin; R-CEOP, rituximab, cyclophosphamide, epirubicin, vincristine, prednisone; RT, radiotherapy.